期刊文献+

两种方法对结核杆菌耐多药性检测结果的比较 被引量:3

Comparison on two methods to evaluate the resistance of Mycobacterium tuberculosis
原文传递
导出
摘要 目的对照比例法,探讨线性探针技术(Genotype MTBDRplus)对耐多药结核分枝杆菌进行快速诊断的应用价值。方法收集宝鸡市2014年部分县区疾控分离培养结核杆菌阳性菌株,以传统药敏技术(比例法)作为对照参比,评价MTBDRplus法对阳性菌株的耐多药性检测以及对异烟肼和利福平耐药性检测的灵敏度、特异性。结果 MTBDRplus法和比例法对耐多药的检出率为均为46.7%,二者的耐多药检出率一致。对照比例法,线性探针技术检测出MDR-TB的敏感性和特异性分别为92.9%和93.8%,检测出异烟肼的敏感性和特异性分别为100.0%和90.9%,检测出利福平的敏感性和特异性分别为94.7%和100.0%,差异均无统计学意义(χ2=0.00,P>0.05)。结论 MTBDRplus法操作简单快捷,结果准确,为耐多药性结核病的快速诊断提供有利依据。因此,该项技术可结合传统药敏在临床上推广应用。 Objective To investigate Genotype MTBDRplus line probe assay for rapid diagnosis of multidrug-resistant tuberculosis compared with conventional drug susceptibility. Methods Compared with conventional drug susceptibility,collecting Mycobacterium tuberculosis clinical isolates in some countries CDC of Baoji city in 2014 for detection by MTBDRplus method to get the sensitivity and the specificity of rifampicin and isoniazid- resistance. Results MTBDR plus assay and conventional drug susceptibility testing for the detection of MDR same rate were 46. 7%. compared to the results of conventional rug susceptibility testing,the sensitivity and specificity of MTBDRplus assay for MDR- TB detection were 92. 9% and 93. 8%. The detection of isoniazid were 100% and 90. 9%,the detection of rifampic were 94. 7% and 100%. There was no significant difference between the 2 methods( χ2= 0. 00,P 〉0. 05). Conclusions MTBD Rplus assay can be used for rapid detection of MDR- TB because of its fast and accurate analysis. So,it should be combined with the conventional drug susceptibility testing to be promoted in clinical practice.
出处 《医学动物防制》 2016年第2期231-233,共3页 Journal of Medical Pest Control
关键词 线性探针 结核杆菌 耐药 Line probe assay Mycobacterium tuberculosis Multidrug-resistant
  • 相关文献

参考文献10

二级参考文献40

  • 1漆沄,石志红,张增贤.西安地区结核耐药性现状调查研究[J].实用医技杂志,2007,14(13):1662-1664. 被引量:5
  • 2T.Heller,R.J.Lessells,C.G.Wallrauch,T.Brnighausen,G.S.Cooke,L.Mhlongo,I.Master,M.L.Newell,弭凤玲,王雪静.南非夸祖鲁纳塔尔农村地区以社区为基础的耐多药结核病治疗[J].国际结核病与肺部疾病杂志,2010(3):110-115. 被引量:17
  • 3马屿.耐多药结核病及其防治[J].临床肺科杂志,2005,10(2):137-140. 被引量:118
  • 4张天民.二芳基喹啉——莫昔沙星后的最强有力的抗结核药物[J].临床肺科杂志,2006,11(1):4-4. 被引量:5
  • 5Dooley SW,Jarvis WR,Martone WJ,et al.Multidrug resisant tuberculosis[J].Ann Intern Med,1992,117(5):2572-2591.
  • 6Musser JM.Antimicrobialagent resistancein Mycobacteria:molecular geneticinsights[J].Clin Microbiol Rev,1995,8(3):4962-5141.
  • 7Migliori GB,Besozzi G,Girardi E,et al.Clinical and operational value of the extensively drug-resistant tuberculosis definition[J].Eur Respir J,2007,30(5):623-626.
  • 8Bang DA, Andersen B, Thomsen VO. Rapid genotypic detec- tion of rifampin- and isoniazid-resistant Mycobacterium tubercu- losis directly in clinical specimens. J Clin Microbiol, 2006, 44 (7) :2605-2608.
  • 9Tortoli E, Marcelli F. Use of the INNO LiPA Rif. TB for de- tection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin sus- ceptibility. Eur J Clin Microbiol Infect Dis, 2007, 26 (1): 51-55.
  • 10Lacoma A, Garcia Sierra N, Prat C, et al. GenoType Mtb- DRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical sam- pies. J Clin Microbiol, 2008, 46(11) :3660-3667.

共引文献84

同被引文献24

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部